BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Prostate
,
Autoimmunity
,
Lovastatin
,
rs4950928
,
SIRT1
,
Metabolism of xenobiotics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
human toll- like receptor 4
Summary
General Info
Curated Studies
Most Correlated Studies
Gastric cancer cells treated with Toll-like receptor(TLR) ligand Pam3Cys-Ser-(Lys)4 and FSL-1
Whole blood of IRAK4-null, MYD88-null and normal donors treated with Toll-like receptor agonists
Toll like receptor (TLR) agonists on human dendritic cells
The response of THP-1 cells to treatments with LPS and TGFb1
B cell-like diffuse large B cell lymphoma TMD8 cells with TLR7 or TLR9 shRNA knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
The pathogenic effect of SNPs on structure and function of human TLR4 using a computational approach…
Dynamics on human Toll-like receptor 4 complexation to MD-2: the coreceptor stabilizing function.
Tracing the evolution of novel features of human Toll-like receptor 4.
Differential expression and prognostic value of TLR4 in kidney renal clear cell carcinoma.
Toll-like receptor 4 in pancreatic damage and immune infiltration in acute pancreatitis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
First in Human Study of an Anti-Toll-like Receptor 4 (TLR4) Monoclonal Antibody (NI-0101) in Adult H…
A Study to Evaluate the Effect of Lipid Infusion on Toll Like Receptor 4 (TLR4) Signaling
Characterization of the Toll-like Receptor 7-agonist Imiquimod 3.75% as a New Surrogate Model of Itc…
Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients
ENABLE (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ